Eat Shit and Prosper • 1 HN point • 14 Dec 22
- The FDA approved Rebyota, a new treatment for serious gut infections that is basically just processed poop, but it comes with a very high price tag of around $9,487, sparking concerns about its affordability compared to existing fecal microbiota transplants.
- Fecal microbiota transplants (FMT) have been used effectively for years but face regulatory challenges, leading to limited access and insurance coverage, which leaves patients with expensive options like Rebyota.
- The FDA's new rules seem to restrict the use of lower-cost stool banks for FMTs, creating a monopoly for companies producing expensive versions, which raises questions about priorities in healthcare and profit vs. patient care.